Sayli Chavan

Principal Associate Scientist @Dragonfly Therapeutics, Inc

Waltham, MA, US

Spearheaded the establishment of Dragonfly’s in-house translational medicine lab, driving key insights into pharmacodynamics (PD), safety, mechanism-of-action and dose selection for clinical stage oncology programs.• Led the design and optimization of multi-color (25 color) flow cytometry panels for in-depth immune cell profiling, providing key data for decision-making in 4 clinical-stage tri-specific antibody and cytokine programs targeting NK and T cells.• Qualified Luminex multiplex cytokine measurement assays under GCP compliance to improve data reliability.• Lead data generation, analysis, interpretation, and presentation; authored multiple SOPs, 2 validation reports and 7 electronic laboratory notebook (ELN) templates to streamline and endure reproducibility across workflows.• Collaborated with cross-functional teams such as Clinical Science, Biomarker and Clinical Operations to align assay strategy with clinical endpoints, expediting data-driven decisions across multiple oncology trials.

The University of Texas at San Antonio

Master’s Degree

Thadomal Shahani Engineering College

Bachelor’s Degree

Harvard Medical School

Certificate of Achievement in HMX Fundamentals-Immunology